MedTrace Logo

Delirium in Children Undergoing Stem Cell Transplantation

NCT04937400 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1040

Last updated 2025-11-14

No results posted yet for this study

Summary

Children undergoing stem cell transplants are at risk for delirium, a temporary change in thinking and behavior. This study will define delirium rates, risk factors, and outcomes. Our eventual goal is to reduce delirium in this population.

Conditions

  • Stem Cell Transplant Complications
  • Delirium

Interventions

OTHER

Daily screening for delirium

Each child will be screened twice daily for delirium throughout the transplant hospitalization

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Chani Traube · Weill Medical College of Cornell University

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-12
Primary Completion
2026-07-30
Completion
2026-07-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04937400 on ClinicalTrials.gov